Skyhawk Therapeutics

Developer of RNA-modifying drug candidates for the treatment of multiple disorders

placeWaltham, Massachusetts, United States calendar_todayFounded 2017 groups86 employees language skyhawktx.com

Innovation

51 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities, Mechanical engineering; filing pace slowing. Cited 4,954 times.

YearFilings
20193
202016
202120
202224
202319
20248
202513
202615

Social engagement

Social engagement: 13.9K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

11 investors on record; lead investors include Disney, Alexandria, Acks, Good Growth Capital.

Investor typeCountShare
Venture capital655%
Private equity19%
Accelerator & incubator19%
Other / undisclosed327%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

5 Dec 2025 · Senior Manager, Regulatory Project Management and Operations · Waltham

Based on job postings tracked across public sources.

Recent activity

29 Jun 2026
Event
EAN 2026 Congress
1 Jun 2026
Product launch
23 Apr 2026
Event
American Academy of Neurology Annual Meeting 2026
Coming soon